Sourasky Medical Center (Ichilov)
| Израиль | Түркия | Австрия | |
| Сүт безі рагында химиотерапия | бастап $22,500 | бастап $1,200 | бастап $15,000 |
| Гамма-пышақ | бастап $13,800 | бастап $6,300 | бастап $32,000 |
| Тік ішек қатерлі ісігінде сәулелік терапия | - | бастап $7,000 | бастап $12,000 |
| Саркомадағы сәулелік терапия | - | бастап $3,250 | бастап $18,000 |
Клиника Ассута (Assuta) — Израильдегі ең ірі жеке медициналық орталық. Госпиталь онкология, ортопедия, нейро-, кардиохирургия және бедеулікті емдеуге маманданған. Елдегі барлық операциялардың 13% Ассутада өткізіледі, бұл оны хирургия бойынша жетекші орталық етеді.
Емдеудің сапасы мен қауіпсіздігі үшін аурухана американдық Joint Commission International аккредитациясын алды.
Әр жыл сайын Ассута желісінің дәрігерлері 92 000-нан астам операция, 685 000 диагностикалық процедура және 16 000 ЭКО циклдарын өткізеді.
Профессор Меримский Сураски медициналық орталығында Юмұсқа тіндер мен сүйек онкологиясы бөлімшесін басқарады. Ол 1995 жылдан бері саркомаларды емдеуге маманданған.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Доктор Дрор Левин — Сураски медициналық орталығында балалардағы сүйек қатерлі ісігін (саркоманы) емдеу бойынша жетекші маман.
Доктор Амир саркоманы емдеуге маманданған, оның хирургиялық онкологиядағы жетістіктері және әскери медицинаға қосқан үлесі үшін марапаттары бар.
Osteosarcoma treatment in Israel follows a rigorous three-stage protocol involving neoadjuvant chemotherapy, limb-sparing surgical resection, and adjuvant chemotherapy. Specialist centers like Sourasky Medical Center and Sheba Medical Center prioritize tumor shrinkage with aggressive drug regimens. This approach enables a 95% success rate for limb-salvage procedures.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center offer highly specialized pediatric-specific protocols that are not available at every general hospital. For example, their allogeneic bone marrow transplant package for pediatric osteosarcoma includes a 30-day hospital stay. This level of intensive inpatient monitoring is a critical differentiator for high-risk childhood cases compared to standard outpatient chemo cycles.
Patient Consensus: Patients note that the recovery phase after limb-salvage surgery is physically demanding. They emphasize the importance of requesting a fertility preservation consultation before starting the first round of aggressive chemotherapy.
Israeli surgeons perform limb-preserving surgery for 90% to 95% of osteosarcoma cases. These procedures prioritize tumor removal while maintaining functional use of the arm or leg. Specialists integrate 3D-modeled implants and navigation-guided resections. This approach successfully replaces amputation as the primary treatment standard.
Bookimed Expert Insight: Israeli orthopedic oncology units, like the one at Sourasky Medical Center active since 1995, manage massive patient volumes exceeding 1.8 million annually. This high frequency allows centers to maintain unique sub-specialties specifically for pediatric bone tumors. For example, Dr. Dror Levin combines oncology with specialized training from Italy’s Rizzoli Institute. Such concentrated expertise is rare and ensures that even complex cases in growing children benefit from the most specialized limb-salvage protocols available globally.
Patient Consensus: Patients note it is important to choose centers that provide multidisciplinary teams, specifically highlighting how orthopedic and plastic surgeons work together. Many mention the relief of avoiding repeated surgeries for children thanks to the remotely adjustable growing implants.
Advanced systemic therapies for metastatic or relapsed osteosarcoma in Israel focus on personalized immunotherapy and targeted drug protocols. Leading facilities like Sheba Medical Center and Sourasky Medical Center provide CAR-T cell therapy, tumor-infiltrating lymphocytes (TIL), and precision tyrosine kinase inhibitors. These treatments aim to stabilize disease and improve survival.
Bookimed Expert Insight: Israeli oncology centers like Sourasky report a 90% success rate in general oncology treatments. This is driven by deep specialization in rare subtypes. For example, Dr. Ofer Merimsky has over 40 years of experience specifically in sarcomas. Clinicians here often lead clinical trials for targeted drugs like Lenvatinib before they become global standards. This provides patients with access to therapies that are not yet available in many other countries.
Patient Consensus: Patients emphasize the importance of requesting Next-Generation Sequencing (NGS) tumor profiling early to identify targeted drug options. Families note that compassionate use programs at hospitals like Sheba can provide access to experimental combinations when standard chemotherapy fails.
Israel hosts globally recognized bone sarcoma centers including Sheba Medical Center, Sourasky Medical Center, and Rambam Health Care Campus. Most facilities hold JCI accreditation and rank among Newsweek’s top medical institutions. These centers specialize in limb-salvage surgery and innovative targeted immunotherapies for osteosarcoma.
Bookimed Expert Insight: While many search for general oncology, the most successful outcomes in Israel occur at centers with dedicated orthopedic oncology units. For example, Sourasky Medical Center has a specialized Head of Metastatic Bone Lesions, Dr. Jakov Bikels. This granular specialization ensures that complex reconstructive surgeries happen alongside tumor removal rather than as a secondary concern.
Patient Consensus: Patients note that the professionalism and expertise of doctors like Dr. Dror Levin provide a pleasant experience. They recommend confirming if an integrated protocol including pathology and limb-salvage surgery is available before traveling.
Limb-salvage surgery in Israel typically requires a 7 to 10 day hospital stay. Patients often stand within 2 to 3 days using assistive devices. Specialized inpatient rehabilitation usually lasts 10 days. Full functional recovery for osteosarcoma patients may extend from 6 months to 1 year.
Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba often integrate orthopedic surgeons directly into oncology teams. This allows patients to bypass local specialized rehab wait times. By choosing a facility with an onsite rehabilitation department, you can consolidate surgical follow-ups and intensive therapy in one city. This frequently shortens the non-weight-bearing phase by 1 to 2 months compared to fragmented care models.
Patient Consensus: Patients emphasize that rehabilitation is a long process requiring persistence and 3 weekly sessions. Many note that preparing for a 9 month non-weight-bearing period is helpful for mental and logistical readiness.